Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-12-02

Clinical Trial Update: Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer

View source ↗

Summary

A post-marketing surveillance study evaluating the safety and effectiveness of abiraterone acetate in adult Filipino men with advanced metastatic castration-res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: Janssen Pharmaceutica | Conditions: Prostate Neoplasms | Status: WITHDRAWN